Background: Most COVID-19 patients have mild or moderate illnesses that can progress to severe illness. leading to hospitalization and/or mortality. The use of antivirals to prevent the progression of COVID-19 in non-hospitalized patients shows conflicting result and efficacy remain unclear. This study evaluates the efficacy and safety of antivirals therapy in COVID-19 outpatients. https://www.chiggate.com/color-charm-050-cooling-violet-supply/